About: http://data.cimple.eu/news-article/6c34a9fef797d04ab5fbf295e4aab8bfd2097593a2ab2366adc2ee71

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/6c34a9fef797d04ab5fbf295e4aab8bfd2097593a2ab2366adc2ee71 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Wall Street stocks surged Tuesday on optimism about a rebound in the United States, as more states emerge from coronavirus shutdowns and drugmakers step up efforts to find a vaccine. The Dow Jones Industrial Average finished up 2.2 percent at 24,995.11. The broad-based S&P 500 gained 1.2 percent to 2,991.77, while the tech-rich Nasdaq Composite Index added 0.2 percent at 9,340.22. Tuesday's session marks the latest instance of US stocks shrugging off near-term economic pain by focusing on the expected improvement in the second half of 2020, assuming the economy bottoms out in the second quarter. Analysts also cited fresh announcements about vaccines as another driver of the market surge. Consumer confidence stabilized in May after two months of sharp declines as shoppers said they were more upbeat about the future, according to a survey from the Conference Board. But Lynn Franco, senior director of economic indicators at the Conference Board, warned of a cloud of "uncertainty hanging over consumers' heads," due in part to a possible second wave of COVID-19 infections. At a banking conference, JPMorgan Chase Chief Executive Jamie Dimon described US consumers as in relatively "good shape" considering the spike in unemployment. That was due in part to aggressive emergency spending programs from Washington and the relative stability of housing prices compared to the recession following the 2008 financial crisis, he said. Dow member Merck gained 1.2 percent after announcing a series of initiatives in response to the coronavirus, including the acquisition of privately-held vaccine company Themis. Biotechnology company Novavax jumped 4.5 percent as it announced it had enrolled the first participants for a phase one trial of a vaccine candidate. The gains came as the New York Stock Exchange (NYSE) resumed floor trading after shuttering for two months due to the coronavirus. Under new NYSE safety protocols, all people on the floor must wear masks and have their temperature taken before they are allowed in. Traders will also be separated by plexiglas and required to respect social distancing rules. jmb/cs
schema:headline	US stocks end up on optimism about vaccines, reopenings
schema:mentions	Novavax S&P 500 Index JPMorgan Chase Cloud computing Biotechnology Great Recession New York Stock Exchange Dow Jones Industrial Average Merck Group Recession Francisco Franco University of Washington Pain Social distancing Vaccine United States Severe acute respiratory syndrome coronavirus 2 Open outcry Poly(methyl methacrylate) Jamie Dimon The Conference Board Consumer confidence NASDAQ Composite »more»
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-05-26 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	71 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software